Multi-pronged approach to improve the level of medical technology innovation

On August 21st, the "China Pharmaceutical Science and Technology Innovation and Development Summit Forum" hosted by the Chinese Pharmaceutical Association, the Chinese Pharmaceutical Association Hospital Pharmaceutical Professional Committee, the Chinese Pharmaceutical Association Pharmaceutical Affairs Professional Committee, and the China Pharmaceutical Association Pharmaceutical Intellectual Property Professional Committee was held in Beijing. . The participating experts focused on how to improve the level of medical science and technology innovation in China and promote the rapid and healthy development of the pharmaceutical industry. They stressed that the upgrading of China's pharmaceutical industry must take the road of scientific and technological innovation. Although China's medical science and technology innovation capability continues to improve, there are still many important issues that need to be improved and solved.

National policy

Is a strong support

The Party Central Committee and the State Council attach great importance to scientific and technological innovation and development, and clearly propose to build our country into an innovative country, and have adopted a series of reforms including deepening institutional reforms, increasing investment in science and technology innovation, and building innovative talents. Major initiatives to encourage, support and protect technological innovation. Academician Sang Guowei, vice chairman of the Standing Committee of the National People's Congress and chairman of the China Pharmaceutical Association, pointed out at the meeting that the State Council issued the "Several Policies to Promote the Accelerated Development of the Biological Industry" and proposed to cultivate the bio-industry into a high-tech field in China. Pillar industry. The “Eleventh Five-Year” Science and Technology Major Project “Major New Drug Creation”, which invested 6.6 billion yuan, was officially launched in May this year. The support of these policies will greatly promote the development of the bio-pharmaceutical industry and the improvement of the innovation level of China's pharmaceutical industry. It is estimated that the total output value of China's pharmaceutical industry is expected to reach 100 billion yuan in 2009, an increase of 20%.

Sang Guowei introduced that during the “Eleventh Five-Year Plan” period, China’s pharmaceutical system innovation transformation stage, the “Major New Drug Creation” special leading group and the organization implementation department organized and implemented the work in strict accordance with the implementation plan approved by the State Council, and implemented the medical reform according to the financial crisis. The special needs of the program, prevention and treatment of influenza A, etc. were carried out. As of the end of April this year, 98% of the “Eleventh Five-Year” research tasks have been deployed, of which * the funding for 121 projects has been allocated, and the funding for the second batch of 874 projects is under comprehensive review.

Sang Guowei revealed in the specific introduction of the progress of the “Major New Drug Creation” project that the research and development of new drugs is progressing steadily. Among them, three new drugs, such as Helicobacter pylori (Hp) vaccine, which have been given key support, have obtained new drug certificates, and the Hp vaccine protection rate is 72.1%. It is one of the world's highest protection rate zui high vaccine; anti-drug resistant L-ortrazole After completing 10 new drugs, all the research work has been completed; 43 new drugs such as anti-tumor drug Hembofen are undergoing phase III clinical trials; the antibacterial drug, Cetoxine Hydrochloride, developed by Shanghai Institute of Traditional Chinese Medicine, after 16 years, won a new class of drugs in April this year. Certificate; a class of anti-tumor drug recombinant human endostatin developed by Tsinghua University, listed in the United States in April 2007... Nearly two-thirds of these new drugs will be the first chemical structure and target in China. A new class of drugs.

Wang Dongjin, president of the China Medical Insurance Research Association, also said at the meeting that the innovation and development of medical technology is facing a rare historical opportunity. The medical reform document clearly pointed out: "To establish a sustainable medical and health science and technology innovation mechanism and talent guarantee mechanism", "to take medical and health science and technology innovation as the focus of national science and technology development, strive to overcome the difficulties of medical science and technology, and provide technical support for the health of the people. Increase investment in medical research, deepen medical and health science and technology system and institutional reform, integrate superior medical research resources, accelerate the implementation of major medical science and technology projects, encourage independent innovation, and strengthen research on key disease prevention technologies and key technologies for new drug development, in medical foundation And new research breakthroughs in applied research, high-tech research, Chinese medicine and integrated Chinese and Western medicine research. This not only points the way for the innovation and development of medical science and technology, clarifies the key points, puts forward requirements, and also from institutional mechanisms and capital investment. The protection is provided.

Wang Dongjin also suggested that the state should create more favorable institutional environment and policy conditions for the innovation and development of medical science and technology. We must create a more relaxed and appropriate environment for enterprises engaged in innovation as a technological innovation subject, especially research funding, financial policies, taxation policies, price policies for innovative drugs, prevention and avoidance of R&D risks, and patent policies for innovative drugs. All necessary reforms must be carried out.

Professor Zhao Zhigang from the Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, said that when comparing the new drug innovation systems in China and the United States, the US government's responsibilities are mainly focused on building a legal environment for the national innovation system, strengthening cooperation between universities and enterprises, and formulating patents and knowledge. The property rights protection policy increases the education and training of the labor force, thus providing services, guidance and protection for enterprise innovation. Since the 1980s, the US government has formulated more than 20 regulations to promote technological innovation, providing continuous motivation for new drug research and development. In view of this, he also stressed: "Innovative drugs are the growth point of the national economy. Its quantity and quality represent the innovation ability of a country. The research and development of innovative drugs requires the support of relevant national policies and requires the support of the state finance. Currently in China. The situation is more prominent."

A Massage Table is generally used by massage therapists to offer a comfortable platform on which the client can lay down to receive a body massage. With the progress of the times and technology, massage table is experiencing from economic and simple design to upscale and functional design with electric motors and hydraulic pump and so on. However, a typical table always has an easily cleaned, heavily padded surface, and a face cradle that allows the client to breathe freely while lying face down.

 

With the usage of the CNC cutting machine, we can easily customize any shape of the massage table with any length and width by programming. We have three categories: Wood Base Electric Massage Table, wood base Electric Massage Table and Metal Base Electric Massage Table. The features you are looking for such as elegance appearance, silent but powerful engine motor driven, easy to control  ,We are sure a large of section of massage table will meet your own need.

wooden massage table

Massage Table

Massage Table,Folding Massage Table,Portable Massage Table,Wooden Massage Table

MING MEI ROYAL SPA FURNITURE , https://www.mingmeibeauty.com

Posted on